You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Anoat Therapeutics receives cystic fibrosis funding boost

Anoat Therapeutics – a company focusing on therapies for cystic fibrosis (CF) – has announced it has raised €2m in seed funding through its AdBio partners.